Methods to study phosphoribosylated ubiquitin ligation and removal

Understanding how ubiquitin is modified and transferred is central to studying cellular regulation. Prior research has shown that ubiquitination typically involves E1, E2, and E3 enzymes. However, some pathogens manipulate this system to evade host defenses. This gap motivated the search for alternative ubiquitination mechanisms. The classical pathway uses ATP to drive ubiquitin conjugation. That uncertainty drove investigations into how bacteria like Legionella pneumophila might alter this process. No prior work had resolved how NAD-dependent ubiquitination functions. This uncertainty led to the discovery of the SidE family of bacterial effectors. These proteins use a distinct mechanism to modify ubiquitin and target host proteins.

This study aimed to describe the experimental methods for studying phosphoribosylated ubiquitination. The researchers focused on the SidE family of effectors from Legionella pneumophila. They wanted to clarify how these proteins catalyze ubiquitin modification. The study also aimed to demonstrate how this modification is reversed. The researchers used SdeA and SidJ to model the process in vitro. This approach allows for detailed biochemical analysis of the pathway. The goal was to provide a reproducible method for future investigations. This work supports studies on how pathogens manipulate host ubiquitination systems.

The researchers used purified SdeA and SidJ proteins for in vitro experiments. They incubated these proteins with ubiquitin and Rab33b, a target GTPase. The reaction conditions included NAD as the energy source. ADP-ribosylation of ubiquitin was monitored using mass spectrometry. Cleavage of ADPR-Ub was assessed by detecting AMP release. The phosphodiesterase activity of SdeA was evaluated using labeled substrates. The transfer of phosphoribosylated ubiquitin to Rab33b was confirmed by immunoblotting. These methods enabled the researchers to track each step of the modification process.

The study found that SdeA catalyzes ADP-ribosylation of ubiquitin at residue Arg42. This forms ADPR-Ub, which is then cleaved by the PDE-related domain of SdeA. Cleavage is coupled to the transfer of phosphoribosylated ubiquitin to Rab33b. The reaction releases AMP as a byproduct. The modification was reversed by SidJ, which removes phosphoribosylated ubiquitin. The reversal was confirmed using mass spectrometry and immunoblotting. The efficiency of ubiquitin transfer was measured at 37°C and pH 7.5. These findings support the role of SidE and SidJ in bacterial ubiquitination.

The authors propose that the SidE family uses NAD to drive ubiquitination. They suggest that ADP-ribosylation is a key step in this process. The cleavage of ADPR-Ub is necessary for phosphoribosylated ubiquitin transfer. The researchers confirm that SidJ reverses this modification. The study supports the hypothesis that Legionella manipulates host ubiquitination. The methods described are suitable for further biochemical investigations. The findings align with the known role of SidE in pathogenesis. These results contribute to the understanding of non-classical ubiquitination pathways.